ArticleJournal of orthopaedic translation2025

Tirzepatide, a dual GLP-1 and GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites.

Ning Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.